The present invention relates to a method of treating a female subject with diminished ovarian reserve or who poorly responds to controlled ovarian […]
The present invention relates to the treatment of nutritional liver diseases or metabolic syndrome. In this study, the inventors aimed to identify […]
The invention relates to an engineered glomerular endothelial cell comprising areduction in expression of a human leukocyte antigen and its use in an […]
Despite the notion that human CD8+ T cells are the final mediators of autoimmune ?-cell destruction in type 1 diabetes (T1D), none of their target […]
The present invention relates to the treatment of cancer. Here, the inventors evaluated EAPB02303 effects in PDAC cell lines and mouse models and […]
The present invention relates to an antibody, which is capable of binding to theNeuromedin N long fragment, and Neurotensin long fragment with high […]
The present invention relates to modified T cells, and in particular to CD8 T cells, for use in therapy. The current inventors investigates the effect […]
The present invention relates to methods and pharmaceutical compositions for the treatment of bacterial superinfections post-influenza. In particular, […]
The present invention relates to methods and pharmaceutical compositions for the treatment of bacterial infections. In particular, the present […]
The present invention relates to the treatment of infections due to antibiotic-resistant bacteria. Antimicrobial resistance (AMR) has been observed at […]